Visual inspection is critical for injectable products because it ensures patient safety by detecting life-threatening particulate contamination and identifying packaging defects like cracks or faulty seals.
Regulatory bodies mandate these checks to guarantee sterility and product integrity prior to administration.
๐๐ก๐ฒ ๐ข๐ฌ ๐๐ข๐ฌ๐ฎ๐๐ฅ ๐๐ง๐ฌ๐ฉ๐๐๐ญ๐ข๐จ๐ง ๐๐จ ๐๐ฆ๐ฉ๐จ๐ซ๐ญ๐๐ง๐ญ?
Injectable medicines are administered directly into the body, leaving little room for error.
Even a small visible defect can compromise product quality and patient safety.
Visual Inspection helps identify defects such as:
- Glass particles
- Rubber fragments
- Fibers
- Black or white particles
- Cracks in vials or ampoules
- Improper seals or closures
- Discoloration or cloudiness
- Incorrect fill volume
๐๐ก๐๐ซ๐ ๐ข๐ฌ ๐๐ข๐ฌ๐ฎ๐๐ฅ ๐๐ง๐ฌ๐ฉ๐๐๐ญ๐ข๐จ๐ง ๐๐๐ซ๐๐จ๐ซ๐ฆ๐๐?
Visual Inspection is commonly performed for:
- Injectable medicines
- Vaccines
- Intravenous (IV) fluids
- Prefilled syringes
- Ampoules
- Vials
- Biopharmaceutical products
It is a critical quality step before products are approved for distribution.
๐๐๐๐ก ๐ฎ๐ง๐ข๐ญ ๐จ๐ ๐ข๐ง๐ฃ๐๐๐ญ๐๐๐ฅ๐ ๐ฉ๐ซ๐จ๐๐ฎ๐๐ญ ๐ฌ๐ก๐จ๐ฎ๐ฅ๐ ๐ฎ๐ง๐๐๐ซ๐ ๐จ ๐จ๐ง๐ ๐จ๐ ๐ญ๐ก๐ ๐๐จ๐ฅ๐ฅ๐จ๐ฐ๐ข๐ง๐ ๐ฉ๐ซ๐จ๐๐๐ฌ๐ฌ๐๐ฌ ๐๐ฌ ๐ฉ๐๐ซ๐ญ ๐จ๐ ๐ฆ๐๐ง๐ฎ๐๐๐๐ญ๐ฎ๐ซ๐ข๐ง๐ :
- Manual Visual Inspection (MVI)
- Semi-Automated Visual Inspection (SAVI)
- Automated Visual Inspection (AVI)
The most commonly used process in pharmaceutical manufacturing is Manual Visual Inspection (MVI), which can be developed through a series of standard steps.
๐๐ฌ ๐ฉ๐๐ซ ๐๐๐<๐๐๐๐>:
- 50-60% of defects should be classified as critical defects,
- 30-35% as major defects and
- 10-15% as minor defects.
Sometimes, the most important quality check is simply looking carefully.
Because in sterile manufacturing, even the smallest visible defect can have the biggest impact on patient safety.
